Inventor · disambiguated record
Charles J. Link
Also filed as: LINK CHARLES · LINK CHARLES J · LINK CHARLES J JR · LINK JR CHARLES J
25 granted patents·11 pending applications·285 citations·filing 1995–2023
96Inventor score
Files withHUMAN GENE THERAPY RES INST9NEWLINK GENETICS CORP7HUMAN GENE THERAPY RESEARCH IN4CENTRAL IOWA HEALTH SYSTEM2LINK JR CHARLES J2
Top patents by PatentIndex Score
36 records- 0189US7998486B2Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopesNEWLINK GENETICS CORP·Filed 2007·Granted Aug 16, 2011·5 cites·9 claims
- 0289US6875610B2Methods and compositions for efficient gene transfer using transcomplementary vectorsHUMAN GENE THERAPY RES INST·Filed 2001·Granted Apr 5, 2005·41 cites·8 claims
- 0386US7763461B2Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyl transferaseIOWA HEALTH SYSTEM·Filed 2006·Granted Jul 27, 2010·13 cites·5 claims
- 0486US5830727AHerpes simplex virus amplicon mini-vector gene transfer systemHUMAN GENE THERAPY RESEARCH IN·Filed 1995·Granted Nov 3, 1998·83 cites·33 claims
- 0585US7005126B1Method for tumor treatment using infusion of xenogeneic cells to induce hyperacute rejection and innocent bystander effectHUMAN GENE THERAPY RES INST·Filed 2000·Granted Feb 28, 2006·18 cites·8 claims
- 0681US8748469B2IDO inhibitorsMAUTINO MARIO R·Filed 2009·Granted Jun 10, 2014·6 cites·7 claims
- 0779US9090643B2Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopesNEWLINK GENETICS CORP·Filed 2012·Granted Jul 28, 2015·1 cites·4 claims
- 0879US8916169B2Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopesNEWLINK GENETICS CORP·Filed 2012·Granted Dec 23, 2014·1 cites·1 claims
- 0975US5843459ADifferential inactivation of nucleic acids by chemical modificationHUMAN GENE THERAPY RESEARCH IN·Filed 1996·Granted Dec 1, 1998·38 cites·21 claims
- 1074US9174942B2IDO inhibitorsNEWLINK GENETICS CORP·Filed 2014·Granted Nov 3, 2015·2 cites·19 claims
- 1171US5869035AMethods and compositions for inducing complement destruction of tissueHUMAN GENE THERAPY RESEARCH IN·Filed 1996·Granted Feb 9, 1999·31 cites·14 claims
- 1268US8551474B2Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferaseLINK JR CHARLES J·Filed 2010·Granted Oct 8, 2013·2 cites·12 claims
- 1367US7125549B2Methods and compositions for efficient gene transfer using transcomplementary vectorsHUMAN GENE THERAPY RES INST·Filed 2001·Granted Oct 24, 2006·1 cites·8 claims
- 1466US9512158B2Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopesNEWLINK GENETICS CORP·Filed 2012·Granted Dec 6, 2016·0 cites·9 claims
- 1565US8357777B2Enhanced immunogenicity of tumor associated antigens by addition of αgal epitopesNEWLINK GENETICS·Filed 2011·Granted Jan 22, 2013·1 cites·1 claims
- 1664US6897020B2Methods and compositions for elucidating relative protein expression levels in cellsNEWLINK GENETICS INC·Filed 2001·Granted May 24, 2005·4 cites·22 claims
- 1761US7078179B2Selectable gene marker system based on expression of N-acetyllactosaminide 3-α galactosyltransferaseNEWLINK GENETICS CORP·Filed 2004·Granted Jul 18, 2006·1 cites·34 claims
- 1858US2006034812A1Method for tumor treatment using infusion of xenogeneic cells to induce hyperacute rejection and innocent bystander effectHUMAN GENE THERAPY RES INST·Filed 2005·Application pending·0 cites
- 1957US2023404642A1Method for the treatment of cancer via tumor cell lysis and intratumoral administration of combinations of immunotherapeutic ingredientsSYNCROMUNE INC·Filed 2023·Application pending·0 cites
- 2055US9474771B2Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferaseCENTRAL IOWA HEALTH SYSTEM·Filed 2013·Granted Oct 25, 2016·0 cites·5 claims
- 2155US9474801B2Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferaseCENTRAL IOWA HEALTH SYSTEM·Filed 2013·Granted Oct 25, 2016·0 cites·7 claims
- 2254US7029665B2Human suppressor tRNA oligonucleotides and methods for use for sameHUMAN GENE THERAPY RES INST·Filed 2001·Granted Apr 18, 2006·3 cites·14 claims
- 2354US2004191873A1Method for high throughput elucidation of transcriptional profiles and genome annotationFiled 2004·Application pending·0 cites
- 2453US6309830B1Human suppressor tRNA oligonucleotides and methods of use for sameHUMAN GENE THERAPY RES INST·Filed 1999·Granted Oct 30, 2001·18 cites·29 claims
- 2553US2016089397A1Correlates of efficacy relating to tumor vaccinesNEWLINK GENETICS CORP·Filed 2014·Application pending·0 cites
- 2652US2005201993A1Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferaseFiled 2004·Application pending·0 cites
- 2751US8535658B2Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferaseLINK JR CHARLES J·Filed 2010·Granted Sep 17, 2013·0 cites·14 claims
- 2850US2004191229A1Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferaseFiled 2003·Application pending·0 cites
- 2949US2004126824A1Ovarian cancer-specific promoterFiled 2003·Application pending·0 cites
- 3047US6342217B1Radiation enhanced gene therapy for tumors expressing a gene for a viral pyrimidine kinase in the presence of a 5′-halogenated pyrimidineHUMAN GENE THERAPY RES INST·Filed 1999·Granted Jan 29, 2002·9 cites·25 claims
- 3147US2005221482A1Methods and compositions for obtaining hematopoietic stem cells derived from embryonic stem cells and uses thereofBURT RICHARD K·Filed 2005·Application pending·0 cites
- 3246US2013149331A1Rhamnose and forssman conjugated immunogenic agentsWANG PENG GEORGE·Filed 2012·Application pending·0 cites
- 3344US2006134629A1Methods and compositions for elucidating protein expression profiles in cellsLINK CHARLES J·Filed 2003·Application pending·0 cites
- 3442US5985266ARadiation enhanced therapy for tumors expressing a gene for viral thymidine kinase in the presence of a 5-halogengated pyrimidineHUMAN GENE THERAPY RESEARCH IN·Filed 1997·Granted Nov 16, 1999·6 cites·13 claims
- 3541US2005266544A1Methods and compositions for increasing viral vector production in packaging cell linesHUMAN GENE THERAPY RES INST·Filed 2005·Application pending·0 cites
- 3633US6541197B2Vehicles for stable transfer of green fluorescent protein gene and methods of use for sameHUMAN GENE THERAPY RES INST·Filed 1997·Granted Apr 1, 2003·1 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Charles J. Link files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →